Can psilocybin be an effective treatment for depression? Western Australia trial aims to find out

An Australian alternative drug company has obtained ethics approval to begin a clinical trial in Western Australia using psilocybin, the active ingredient in magic mushrooms, to treat depression. The trial will involve around 60 participants and will be conducted at Fiona Stanley Hospital in Perth. UWA Professor Sean Hood is the principal investigator of the trial, and each participant will receive two doses of 25 milligrams of the drug a month apart, followed by a comprehensive psychotherapy regime.

This trial, set to begin in mid-2023, is the first in Australia to utilize legally grown, pharmaceutical-grade psilocybin.

The use of psychedelic treatments such as psilocybin may be a final option for individuals with treatment-resistant mental illnesses.

In early February, MDMA and psilocybin was approved by TGA for medical use in Australia.

Within six months after approval, individuals with severe mental health issues will be able to receive prescriptions for the psychedelics MDMA and psilocybinThe Therapeutic Goods Administration approved the change after calls to reclassify the drugs, however, only authorized psychiatrists can prescribe them.

MDMA, commonly referred to as ecstasy or Molly, is a type of psychoactive substance that functions as a stimulant. It works by releasing certain chemicals in the brain, which leads to an increase in energy levels, heightened senses, and heightened emotions such as self-awareness and empathy.

Experts are exploring the potential benefits of MDMA through various trials. The goal is to find effective ways to conduct an MDMA-assisted therapy, particularly for patients suffering from PTSD. 

The Mind-Bending Connection Between Psychedelics and Neuroplasticity

The Mind-Bending Connection Between Psychedelics and Neuroplasticity

and how these substances may have therapeutic potential for mental health

Breaking the Stigma: Psychedelic Subtypes Yield Consistent Depression and Anxiety Relief

Breaking the Stigma: Psychedelic Subtypes Yield Consistent Depression and Anxiety Relief

Optimizing personal and mystical insight experiences may be crucial in

You May Also Like

Join Psilolab Newsletter!

Welcome to the Psilolab newsletter, where we delve into the fascinating world of psychedelics and their impact on mental health. In this space, we explore the latest research and breakthroughs in the field of psychedelics and how they are being used to treat various mental health conditions such as depression, anxiety, PTSD, and addiction.

Join us on this journey as we explore the mind, reality, and the transformative power of psychedelics.